Sherbrooke Park Advisers’s Chemed CHE Stock Holding History

Sherbrooke Park Advisers’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,392	Closed	-$755K	–	948
2024 Q2	$755K	Buy	+1,392	New	+$797K	0.13%	251

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Sherbrooke Park Advisers's CHE Position: Q3 2024 in Review

Sherbrooke Park Advisers sold out of Chemed (CHE) in Q3 2024, closing a stake of 1,392 shares — an estimated $755K sold.

Sherbrooke Park Advisers first reported a position in CHE in Q2 2024 and held it in 1 quarter. The position peaked at $755K in Q2 2024. 527 funds tracked by Wall St. Rank hold CHE as of Q3 2024.

Sherbrooke Park Advisers reported no remaining Chemed position as of Q3 2024 after selling out during the quarter.
Sherbrooke Park Advisers sold 1,392 Chemed shares in Q3 2024, an estimated $755K.
Sherbrooke Park Advisers first reported a position in Chemed in Q2 2024 and held it in 1 quarter.
Sherbrooke Park Advisers's Chemed position peaked at $755K in Q2 2024.
527 funds tracked by Wall St. Rank held Chemed as of Q3 2024.

Based on Sherbrooke Park Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.